Perkinelmer News

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that it is expanding its OneSource Laboratory Services offering to include strategic laboratory consulting services.

PerkinElmer, Inc. , a global leader in maternal and fetal health, and Verinata Health, an Illumina company and innovator of non-invasive prenatal tests , today announced that several of the top health insurance plans have expanded coverage of the verifiA prenatal test for a variety of potential fetal health risks to over 80 million covered lives.

PerkinElmer, Inc. , a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the UBS Global Healthcare Conference on Monday, May 20, 2013, at 4:00 pm Eastern Time at the Sheraton New York Hotel and Towers in New York City.

The dividend will be an 'eligible dividend' for Canadian income tax purposes. The ex-dividend date is May 21, 2013.

PerkinElmer, Inc. , a global leader focused on improving the health and safety of people and the environment, is introducing the newest version of Lead Discovery for the TIBCO Spotfire software platform at the Company's Revolutionaries for Global Health Summit .

Custom stock reports and news alerts for Dundee Industrial Real Estate Investment Trust and Parkland Fuel Corporation are now available on Stockboard.com To get your own custom stock report and news alert service for the above-mentioned companies, please follow the links below: Stockboard.com is an investment website that makes it easy to keep ... (more)

Parkland Fuel Corp posted its quarterly earnings results on Tuesday. The company reported $0.42 earnings per share for the quarter, AnalystRatingsNetwork.com reports.

Recently, I've been closely following biotech companies that are developing novel technologies focused on early detection/screening. Here's why: Healthcare costs have been growing at an alarming rate, of which progressive diseases that have progressed to their late stages account for a large portion .

Mizuho currently has a buy rating on the stock. A number of other analysts have also recently weighed in on PKI.

The imminent expectation of multiple product launches during the course of the coming year and the further development of a pipeline full of urine-based diagnostics designed to detect various cancers and infectious diseases placed Trovagene Inc on the map during the closing half of 2012, especially when shares nearly quadrupled in value in ... (more)

They currently have a C$19.25 target price on the stock. Shares of Parkland Fuel Corp traded up 1.06% during mid-day trading on Thursday, hitting $16.27. Parkland Fuel Corp has a one year low of $13.05 and a one year high of $20.30. The stock's 50-day moving average is currently $17.18. The company has a P/E ratio of 12.58. The company also ... (more)

The meeting program will feature world-renowned experts presenting key insights on finding, understanding, and acting upon the causes and effects of disease including cancer, diabetes and heart disease.

's stock had its "neutral" rating restated by Zacks in a research report issued to clients and investors on Monday, StocKRatingsNetwork.com reports.

The firm currently has a "buy" rating on the stock. Other equities research analysts have also recently issued reports about the stock.

On The Fly: Analyst Downgrade Summary Today's noteworthy downgrades include: AB InBev downgraded to Conviction Sell from Sell at Goldman... Alkermes downgraded to Underperform from Neutral at BofA/Merrill... AmerisourceBergen downgraded to Neutral from Outperform at RW Baird... Baidu downgraded to Hold from Buy at Brean Capital... Embraer ... (more)

PerkinElmer 's stock is down about 10% on Friday after missing consensus expectations for its 1Q earnings on both the top and bottom line, and lowering its full year outcome for 2013 due to weaker demand.

Check below for free stories on BUD;ALKS;ABC;BIDU;ERJ;FFIV;INGR;NATI;PKI;PDH;RJF;USG;WIN;DRC;BC;DAVE;UTHR;UFS;DPM;EXLP;XOM;VIVO;SIMO;XIDE;DRE;CRR the last two weeks.

's stock had its "sector outperform" rating reiterated by investment analysts at CIBC in a note issued to investors on Thursday, AnalystRatings.Net reports.

Good day, ladies and gentlemen, and welcome to the Quarter 1 2013 PerkinElmer Earnings Conference Call.

PerkinElmer issued an update on its FY13 earnings guidance on Thursday morning. The company provided earnings per share guidance of $2.00-2.10 for the period, compared to the Thomson Reuters consensus estimate of $2.29, AnalystRatingsNetwork.com reports.